Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Stock Quote Today & Recent News Antibe Therapeutics T.ATE

Alternate Symbol(s):  ATBPF

Antibe Therapeutics Inc is leveraging its proprietary hydrogen sulfide platform to develop next-generation safer therapies to target inflammation arising from a wide range of medical conditions. The company's pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs. Antibe's lead drug, otenaproxesul, is in clinical development as a safer alternative to opioids for post-operative pain. Antibe's second pipeline drug, ATB-352, is being developed for a specialized acute pain indication. The company's anticipated next target is inflammatory bowel disease, a condition long in need of safer, more effective therapies.

The Power Play by The Market Herald
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Stock Price Chart (TSX:ATE)

Fundamentals Snapshot (TSX:ATE)

Bullboard Posts (TSX:ATE)

5 weeks until financials, 4 months P2 results

<< View Post To Watch Video >>
Duster340 - 6 hours ago

RE:News after thanksgiving

Yes Sir Magic - looking forward to it !!! Always seems to be a moving target - but - we'll get it eventually. Lots still to be...
MrMugsy - 1 day ago

Q2 financials mid november

thats when we officialy will find out that P2 did in fact start at the end of september. i am not expecting any news before then.
Duster340 - 1 day ago

News after thanksgiving

IR indicated no delays for trial start and more in a NR after thanksgiving (canadian thanksgiving that is). Don't take my word for...
themagicbox - 1 day ago

as far as i know

nobody has an anti-ageing supplement. if ate got there act together they could have something on the shelf before the end of the year lol...
Duster340 - 2 days ago

Prevagen (no fda approval needed)

Three million people are estimated to have purchased Prevagen since it was first launched by Quincy Bioscience, a Wisconsin-based...
Duster340 - 2 days ago